Tetratherix (ASX:TTX) Common Stock: A$47.21 Mil (As of Dec. 2025)


ASX:TTX Tetratherix Ltd ASX:TTX
15 GF Score
Price A$5.88
View Full Analysis

What is Tetratherix Common Stock?

Tetratherix ASX:TTX +0.51% 15 Common Stock is A$47.21 Mil as of Dec. 2025. GuruFocus rates ASX:TTX with a GF Score™ of 15/100.

Tetratherix's quarterly common stock increased from Dec. 2024 (A$47.01 Mil) to Jun. 2025 (A$47.21 Mil) but then stayed the same from Jun. 2025 (A$47.21 Mil) to Dec. 2025 (A$47.21 Mil).

Tetratherix's annual common stock stayed the same from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil) but then increased from Jun. 2024 (A$0.00 Mil) to Jun. 2025 (A$47.21 Mil).

Tetratherix Common Stock Historical Data

* Premium members only.

The historical data trend for Tetratherix's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix Common Stock Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25
Common Stock
0.00 0.00 47.21

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial 0.00 0.00 47.01 47.21 47.21
ASX:TTX
15GF Score
Tetratherix Ltd ASX:TTX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$47.21 Mil mean?
Tetratherix (ASX:TTX) has a Common Stock of A$47.21 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tetratherix and its competitors.
Is Tetratherix's Common Stock too high?
Tetratherix's current Common Stock is A$47.21 Mil. Overall, Tetratherix has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's Common Stock compare to VRTX and REGN?
Tetratherix's Common Stock of A$47.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tetratherix and its competitors. Tetratherix's current Common Stock is A$47.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current Common Stock of A$47.21 Mil. The current Common Stock is A$47.21 Mil. Tetratherix's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current Common Stock is A$47.21 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
15GF Score

Get the complete analysis for ASX:TTX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.88
Price